Paperpal Prime Logo

Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring : Impact Factor & More

eISSN: 2352-8729pISSN: 2352-8729
JournalOpen Access

Key Metrics

CiteScore
7
SNIP
1
Recommended pre-submission checks
Powered by Paperpal by Editage

Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher Wiley-Blackwell
Language English
Frequency Continuous publication
Article Processing ChargesUSD 2200
Publication Time8
Editorial Review ProcessBlind peer review
General Details
LanguageEnglish
Society/Institute/SponsorThe Alzheimer's Association
FrequencyContinuous publication
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 8
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessBlind peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
License typeCC BY, CC BY-NC, CC BY-NC-ND
OA statementVisit website
View less

Planning to publish in Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring

Identification of patients receiving amyloid\u2010targeting therapies in observational studies using amyloid PET trajectories: Insights from LEADS
  • 22 Jun 2026
  • Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
Features predicting data exclusion in imaging studies of Alzheimer's disease
  • 21 Jun 2026
  • Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
Regional amyloid PET asymmetry and long\u2010term clinical trajectory in mild cognitive impairment
  • 21 Jun 2026
  • Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
Heritability of Alzheimer's disease\u2013related plasma biomarkers in the Amish population
  • 21 Jun 2026
  • Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
\u201cDoctor, if it were you, which would you choose?\u201d: Navigating personal preference questions in anti\u2010amyloid immunotherapy selection
  • 17 Jun 2026
  • Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
Heterogeneous trajectories of executive function in clinical Alzheimer's disease: Results from the 3C study
  • 16 Jun 2026
  • Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
Identification of patients receiving amyloid\u2010targeting therapies in observational studies using amyloid PET trajectories: Insights from LEADS
  • 22 Jun 2026
  • Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
Features predicting data exclusion in imaging studies of Alzheimer's disease
  • 21 Jun 2026
  • Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
Regional amyloid PET asymmetry and long\u2010term clinical trajectory in mild cognitive impairment
  • 21 Jun 2026
  • Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
Heritability of Alzheimer's disease\u2013related plasma biomarkers in the Amish population
  • 21 Jun 2026
  • Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
\u201cDoctor, if it were you, which would you choose?\u201d: Navigating personal preference questions in anti\u2010amyloid immunotherapy selection
  • 17 Jun 2026
  • Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
Heterogeneous trajectories of executive function in clinical Alzheimer's disease: Results from the 3C study
  • 16 Jun 2026
  • Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring

FAQs on Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring